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Abstract We present the complete amino acid sequence of 
Imperatoxin A (IpTxa), a 33-amino-acid peptide from the venom 
of the scorpion P. imperator which activates Ca2 + release 
channels/ryanodine receptors (RyR) of sarcoplasmic reticulum 
(SR). The amino acid sequence of IpTxa shows no homology to 
any scorpion toxin so far described, but shares some homology to 
the amino acid sequence of Tx2-9 and agelenin, two spider toxins 
that target neuronal P-type Ca2 + channels. We also describe the 
total synthesis of IpTxa and demonstrate that it efficiently 
activates RyRs with potency and affinity identical to those of 
native IpTxa. The use of synthetic IpTxa should help in the 
identification of the structural motifs of RyR critical for channel 
gating. 
© 1997 Federation of European Biochemical Societies. 
Key words: Ca 2 + release channel; Sarcoplasmic reticulum; 
Pandinus imperator scorpion venom; Caffeine; Synthetic 
peptide 
1. Introduction 
Ryanodine receptors (RyR) are essential for maintaining 
the intracellular Ca 2 + homeostasis in striated muscle and in 
a variety of non-excitable cells [1,2]. Their role in excitation-
contraction coupling of cardiac and skeletal muscle is well 
established [3], and their participation in stimulus-secretion 
coupling of secretory cells [4], and elevation of [Ca2 +]; in 
neurons [5], is increasingly evident. In all of these cells, RyR 
releases massive amounts of Ca 2 + from intracellular Ca 2 + 
pools in response to a variety of triggering signals. 
To this point, ryanodine has been the major probe used for 
structural and functional studies of RyRs. The alkaloid binds 
to RyRs with high affinity and specificity, and there is a con-
sensus that [3H]ryanodine binding is an indicator of the num-
ber of receptors that are in the open conformational state [6]. 
However, ryanodine also displays some undesirable features 
that limit its use in experiments with intact cells, such as its 
slow association and dissociation rates, and its behavior as 
both an agonist and a blocker depending on the concentration 
used [6,7]. 
Scorpion venoms have traditionally represented excellent 
sources of ionic channel-blocking peptides. In the venom of 
the scorpion P. imperator we found Imperatoxin A (IpTxa), a 
short peptide that specifically and with high affinity increased 
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[3H]ryanodine binding and enhanced the activity of RyRs 
reconstituted in planar lipid bilayers [8,9]. At concentrations 
well above the half-maximal effective concentration (ED5 0) 
exhibited for RyRs, IpTx a did not affect other Ca
2 + channels 
or ion transporters of muscle and brain [8]. Moreover, all of 
these effects could be seen only on skeletal-type RyR, suggest-
ing that IpTx a preferentially affects this particular RyR iso-
form [9]. However, the use of this promising agent has been 
hampered by the extremely small amount of peptide obtained 
from the whole venom. 
In this paper we communicate the entire amino acid se-
quence of IpTx a and describe the synthesis of an IpTx a analog 
that displays functional properties identical to those of the 
authentic native IpTx a . The design of a fully functional syn-
thetic IpTx a analog should alleviate the problem associated 
with the scarcity of IpTx a and accelerate its use as a peptide 
probe of RyR function. 
2. Materials and methods 
2.1. Purification of IpTx^ 
IpTxa was purified from P. imperator scorpion venom in three 
chromatographic steps. Crude venom was extracted from C02-anes-
thetized scorpions kept alive in the laboratory, recovered with deion-
ized water, and lyophilized. Batches (100 mg) of crude venom were 
dissolved in 2-3 ml of deionized water and applied onto a column 
(1.5X125 cm) of Sephadex G-50 fine. Fractions were eluted with 20 
mM NH4AcOH (pH. 4.7) at a flow rate of 10 ml/h. Fraction 3 con-
taining IpTxa was applied to a column (1 X 25 cm) of carboxymethyl 
cellulose 32 (Pharmacia) equilibrated with 20 mM NH4AcOH (pH 
4.7). Peptides were eluted at a flow rate of 12 ml/h with a linear 
gradient of 250 ml of 20 mM NH4AcOH (pH 4.7) and 250 ml of 
the same buffer containing 0.5 M NaCl. The peak containing IpTxa 
eluted when the NaCl concentration at the top of the column reached 
340 mM. This fraction was concentrated by vacuum centrifugation 
and injected into an Aquapore C§ reverse-phase HPLC column 
(Pierce). IpTxa was eluted with a linear gradient of 0-100% acetonitrile 
in 0.075% trifluroacetic acid (TFA) run at 1 ml/min for 60 min. IpTxa 
was quantified by absorbance at 280 nm (A28oIlm) using an extinction 
coefficient (e)= 1852 M"1 cm"1. 
2.2. Preparation of sarcoplasmic reticulum vesicles and [3HJryanodine 
binding assay 
Heavy sarcoplasmic reticulum (SR) was prepared from rabbit white 
back and leg muscle using the procedure of Meissner [10]. 
[3H]Ryanodine binding to rabbit skeletal SR was carried out as pre-
viously described [8,9]. Briefly, the standard incubation medium con-
tained 0.2 M KC1, 1 mM Na2EGTA, 10 mM Na-Pipes, pH 7.2 and 
CaCl2 necessary to set [free Ca2~] in the range of 1 nM to 100 uJVI. 
Ca2+/EGTA ratios were calculated using the stability constants of 
Fabiato [11]. [3H]Ryanodine (68.4 Ci/mmol, Dupont NEN) was di-
luted directly in the incubation medium to a final concentration of 
7 nM. Protein concentration was in the range of 0.2-0.4 mg/ml and 
was determined by the Bradford method. Incubations lasted 90 min at 
36°C. Samples (0.1 ml) were always run in duplicate, filtered on What-
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man GF/B glass fiber filters and washed twice with 5 ml of distilled 
water using a Brandel M24-R cell harvester (Gaithersburg, MD). 
Nonspecific binding was determined in the presence of 10 (J.M unla-
beled ryanodine and has been subtracted from each sample. Equili-
brium binding data were fitted by nonlinear regression analysis with 
the functions specified in the text using the computer program Origin 
4.0 (Microcal Inc., Northampton, MA). 
2.3. Amino acid analysis and microsequencing of IpTx& 
Amino acid analysis of IpTxa was performed on samples hydro-
lyzed in 6 N HC1 with 0.5% phenol at 110°C in evacuated, sealed 
tubes as described [12]. Reduction of IpTxa with dithiothreitol, and 
alkylation with iodoacetic acid was performed as described [12]. The 
sequence of the intact native and reduced/carboxymethylated IpTxa 
was determined using a model 6400/6600 automatic liquid-phase pro-
tein sequencer (Milligen/BioSearch Prosequencer) employing standard 
Edman degradation programs and CD immobilon membranes. To 
confirm the correctness of the carboxy-terminal sequence, 20 |Xg of 
IpTxa was hydrolyzed with 5. aureus V8 in 100 mM ammonium 
bicarbonate (pH 7.8). The peptide fragments were purified as de-
scribed and directly sequenced as described for native IpTxa. 
2.4. Synthesis of IpTxg, 
A linear analog of IpTxa was synthesized by the solid-phase meth-
odology with Fmoc-amino acids in an Applied Byosystems peptide 
synthesizer (model 432A). After cleavage with 90% trifluoroacetic acid 
for 4 h at room temperature, the crude linear peptide was extracted 
with 5% acetic acid and dried by vacuum centrifugation. The cycliza-
tion reaction to make disulfide bridges in the molecule was carried out 
in 0.1 M NaCl, 5 mM reduced glutathione, 0.5 mM oxidized gluta-
thione, 20 mM NaHP0 4 (pH 8.0) and 30 uM of synthetic IpTxa. The 
crude cyclized product was purified in a Cg reverse-phase HPLC col-
umn using the conditions described in the text. The structure and the 
purity of the synthetic toxin were confirmed by analytical HPLC, 
amino acid analysis and mass spectrometry. For amino acid analysis, 
synthetic toxin was hydrolyzed in 350 JJ.1 of 6 N HC1, 15 jxl of phenol 
at 165°C for 50 min, then analyzed in an Applied Biosystems analyzer 
(model 421). Mass spectrometry was carried out in a Bruker Reflex II 
MALDI-TOF spectrometer. 
2.5. Sequence comparisons 
The amino acid sequence of IpTxa was compared with those of 
other proteins deposited in the protein database of GenBank (Los 
Alamos National Laboratory, Los Alamos, NM) by computer anal-
ysis using the program Blitz version 1.5 (Biocomputing Research 
Unit, University of Edinburgh, UK). 
3. Results and discussion 
Whole P. imperator scorpion venom completely inhibited 
o 
00 
.o 
< 
0.5 
0.4 
0.3 
0.2 
0.1 
0.0 
20 30 40 50 60 
Fraction number 
70 80 
o 
CD 
CM 
0.30 
0.15 
0.00 
100 150 
Fraction number 
m 
1.5 
1.0 
0.5 
0.0 
IpTx 
/ 
w 
10 20 30 
Time (min) 
40 
CO 
a: 
350 
300 
250 
0.01 0.1 1 10 100 
[Venom Component], (ig/ml 
Fig. 1. Purification of IpTxa. A: P. imperator soluble venom (120 mg protein) was applied to a Sephadex G-50 column (0.9x190 cm) equili-
brated and run with 20 mM NH4AcOH (pH 4.7). Samples (5 ml) were collected and tested for their capacity to modify [
3H]ryanodine binding. 
B: Fraction 3 was further separated through a CM-Cellulose column (0.9x30 cm), equilibrated and run with 20 mM NH4AcOH (pH 4.7). 
A linear gradient of sodium chloride resolved multiple sub-fractions, one of which (labeled with arrow) contained IpTxa. C: The sub-fraction 
from the CM-cellulose column containing IpTxa was lyophilized and injected into a Cg reverse-phase HPLC column and eluted with a 0-100% 
linear gradient of acetonitrile containing 0.075% trifluoroacetic acid. D: Dose-response curve for whole venom and purified components. 
[3H]Ryanodine (7 nM) was incubated with skeletal SR protein in 0.2 M KC1, 10 uM CaCl2, 10 mM Na-HEPES pH 7.2, in the absence (con-
trol, 100%) and the presence of indicated concentrations of venom components. Nonspecific binding was determined in the presence of 20 uM 
ryanodine and has been subtracted from this and subsequent results. 
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Fig. 2. Amino acid sequence of IpTxa and comparison with other scorpion and spider toxin sequences. The amino acid sequence of IpTxa was 
obtained by direct Edman degradation of the reduced and alkylated IpTxa. Gaps (—) in the amino acid sequence of Pi-1 and Pi-3, two K
+ 
channel blockers from the scorpion P. imperator [13,14], as well as in Tx2-9, a P-type Ca2+ channel blocker from the spider P. nigriventer [16], 
have been introduced to maximize homology. Agelenin, also a spider toxin that blocks P-type Ca2+ channel [17], is presented without gaps. 
[3H]ryanodine binding to skeletal SR with a concentration of 
15 ng/ml yielding the half-maximal effect (ED50) (Fig. ID, see 
also [8]). The presence of components that stimulate RyRs is 
only apparent after separation of the stimulatory and inhib-
itory components. The purification of IpTxa, an activator of 
RyRs, was performed in three chromatographic steps as de-
scribed in the Section 2 and shown in Fig. 1. After fractiona-
tion of whole venom in Sephadex G-50 (Fig. 1A), five frac-
tions were collected and assayed for effects on [3H]ryanodine 
binding. Fraction 2 contained peptides in the range of 10-20 
kDa that were responsible for the inhibitory effect exhibited 
by the whole venom. Fraction 3 increased [3H]ryanodine bind-
ing with an ED50 = 0.19 |Xg/ml (Fig. ID), but since it accounts 
for <5% of the total venom, its effect is probably masked in 
the whole venom by that of Fraction 2. Fraction 3 was sub-
sequently applied to a carboxymethyl-cellulose and eluted 
with a gradient of NaCl (Fig. IB). The peak containing IpTxa 
(marked by an arrow) eluted late in the run, suggesting that 
IpTxa was a strongly basic peptide. Fig. 1C shows the chro-
matographic profile of IpTxa (marked with an arrow) after 
elution from a reverse-phase Cg HPLC column. IpTxa in-
creased [3H]ryanodine binding with an ED50 = 0.016 ug/ml. 
Given this value and the molecular weight of IpTxa (3.7 
kDa, see below), the apparent dissociation constant (K&) 
was -5 nM. The proportion of IpTxa in the whole venom is 
very small, about 0.03%, but since it displays a high potency 
to stimulate RyRs, the [3H]ryanodine binding assay offers a 
sensitive method to track its functional activity. 
Fig. 2 shows the complete amino acid sequence of IpTxa as 
determined by direct automated microsequencing. IpTxa is 
composed of 33 amino acids with a calculated A/r — 3765. 
As most short scorpion toxins, IpTxa is a basic peptide con-
taining three pairs of cysteine residues that stabilize the three-
dimensional conformation by forming disulfide bridges. Fig. 2 
also shows a comparison of the amino acid sequence of IpTxa 
with those of Pi-1 and Pi-3, two peptide blockers of K+ chan-
nels from the same P. imperator venom [13,14], reportedly the 
smallest ionic channel-targeted scorpion peptides. Pi-3 is rep-
resentative of a group of homologous toxins with three disul-
fide bridges such as noxiustoxin, charybdotoxin, iberiotoxin, 
etc. (for a review, see [15]); Pi-1 forms a K+ toxin subgroup 
on its own by having the remarkable characteristic of possess-
ing four disulfide bridges [13]. No significant similarity is ob-
served between IpTxa and any of these toxins, even when gaps 
(-) are introduced at the level of Cys10 to maximize homology. 
Even less homology is found when the comparison involves 
the larger Na+ channel-selective peptides from scorpion ven-
oms (not shown). Thus, IpTxa constitutes a novel class, the 
smallest yet, of scorpion toxins targeted against ionic chan-
nels. 
Albeit not dramatic, a higher sequence homology was 
found when the comparison was made with Tx2-9 of the 
spider P. nigriventer [16], and agelenin of the spider A. asperta 
[17], two peptide blockers of neuronal P-type calcium chan-
nels (Fig. 2). If gaps are introduced to maximize homology, 
Tx2-9 is the most similar with 45% sequence identity. Agele-
nin has only limited resemblance (21%> sequence identity), 
although higher homology may be ascribed if two-residue 
gaps are introduced. Regardless of the extent of similarity, 
it is clear that IpTxa is more related to these two spider toxins 
than to other toxins present in scorpion venoms. Thus, IpTxa 
adds to the emerging notion that peptide toxins found in 
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Fig. 3. HPLC comparison of native and synthetic IpTxa. Native 
and Synthetic IpTxa (-1.5 nmol each), as well as an equimolar mix-
ture (-1 nmol each) were chromatographed on a Pierce C8 analyti-
cal column. The peptides were eluted using 0.075% trifluoroacetic 
acid as solvent, applying a linear gradient from 0 to 100% (v/v) of 
acetonitrile at a flow rate of 1 ml/min. 
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venomous animals of different phyla contain similar structural 
motifs [18]. 
We used the IpTxa amino acid sequence to synthesize a 
linear analog of IpTxa. After purification and cyclization of 
the synthetic analog as described in Section 2, synthetic IpTxa 
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Fig. 4. Functional properties of synthetic IpTxa. A: Dose-response 
relation for native (O) and synthetic IpTxa (•). [
3H]Ryanodine (7 
nM) was incubated with skeletal SR in the standard incubation me-
dium described in Section 2 in the presence of the indicated concen-
trations of IpTxa. Both sets of data points were fitted with the same 
line. Ki was 5 nM and -Bmax was 325%, which corresponded to 2.36 
pmol/mg protein. B: Effect of synthetic IpTxa on the Ca
2+-depend-
ence of [3H]ryanodine binding. The standard binding medium con-
tained 1 mM EGTA and several CaCl2 concentrations to yield the 
desired [free Ca2+]. Synthetic IpTxa (1 uM) was present throughout 
the incubation period. Smooth lines linking data points have no the-
oretical meaning. C: Potentiation of synthetic IpTxa effect by caf-
feine. The binding of [3H]ryanodine was determined in incubation 
medium containing 100 nM free Ca2+ (1 mM EGTA and 385 |0,M 
CaCy. Caffeine was added at the beginning of the incubation as 
10-jj.l aliquots from 100-fold stocks for concentrations up to 10 
mM, and as powder form to reach 20 mM. 
was analyzed by reverse-phase HPLC for comparison with 
native IpTxa (Fig. 3). The elution time of synthetic IpTxa 
was identical to that of native IpTxa, and a single sharp 
peak was observed upon mixing synthetic and native IpTxa. 
We also tested the functional activity of synthetic IpTxa. 
Fig. 4A shows that synthetic IpTxa increased [
3H]ryanodine 
binding to skeletal SR with the same potency and affinity as 
native IpTxa. Both sets of data points were overlapping and 
could be fitted with the same line. We used the function: 
B = Bmaxn+(Kd+[lpTxa])
n to fit the data, where B is the spe-
cific binding of [3H]ryanodine, 5 m a x is the maximal activation 
of [3H]ryanodine binding evoked by IpTxa (325%), K& is the 
apparent dissociation constant of IpTxa (5 nM), and n is the 
Hill number (1.58). Unlike this dramatic effect on skeletal 
RyR, no significant activation of [3H]ryanodine binding to 
cardiac SR was observed with synthetic IpTxa (results not 
shown)). Hence, synthetic IpTxa also displays selectivity for 
skeletal-type RyRs, just as native IpTxa does. 
In a previous study [9], we reported that native IpTxa in-
creases [3H]ryanodine binding by sensitizing RyRs to Ca2+. 
Fig. 4B shows the Ca2+-dependence of [3H]ryanodine binding 
to skeletal SR and the effect of synthetic IpTxa. Specific bind-
ing in the absence of the peptide (Fig. 4B, Control, o ) had a 
threshold for detection at />Ca 7-6 and was maximal at -50 
uM [Ca2+]. In the presence of 1 uM synthetic IpTxa (Fig. 4B, 
+Synthetic IpTxa, • ) , the threshold for detection of 
[3H]ryanodine binding decreased to />Ca 8 and the binding 
curve was dramatically augmented in absolute values. The 
EC50 for the activation of [3H]ryanodine binding by Ca2+ 
(ascending limb of the curve) was -5 |xM and 0.8 LtM for 
control and synthetic IpTxa, respectively. Thus, synthetic 
IpTxa also activates [
3H]ryanodine binding by sensitizing 
RyRs to Ca2+. 
Another functional attribute of native IpTxa was its ability 
to potentiate its effect with caffeine [9]. Fig. 4C shows the 
interaction of caffeine and synthetic IpTxa. At />Ca 7, binding 
was 0.02 pmol/mg in the absence of synthetic IpTxa and caf-
feine and increased to 0.39 pmol/mg in the presence of 20 mM 
caffeine (Fig. 4C, CO- In the presence of 1 |xM synthetic IpTxa 
(Fig. 4C, • ) , binding was 1.52 pmol/mg in the absence of 
caffeine and increased to 4.51 in the presence of 20 mM caf-
feine, i.e., a net gain of -3 pmol/mg. Since the binding incre-
ment evoked by the combined addition of synthetic IpTxa and 
caffeine was larger than that evoked by caffeine or synthetic 
IpTxa alone, this suggested a cooperative interaction between 
the synthetic IpTxa- and caffeine-binding sites. 
A mass spectrometry analysis of native and synthetic IpTxa 
yielded the expected molecular mass (3765.8 Da) based on 
amino acid composition and sequence. Thus, by all structural 
and functional criteria applied, synthetic IpTxa is identical to 
native IpTxa. The design of a synthetic analog of IpTxa with 
functional attributes identical to the native IpTxa verifies the 
correctness of the amino acid sequence, since even single ami-
no acid substitutions in analogous peptides result in large 
changes of affinity towards their acceptor site [13]. The avail-
ability of relatively large amounts of synthetic IpTxa should 
accelerate its use as a peptide probe of RyR function. 
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